人体膀胱移行上皮癌细胞系(TSB-90,TSB-91)的建立及其生物学特性

从1例膀胱癌患者的癌组织培养中，分离得到2个不同生长特性的悬浮生长型细胞系，定名为TSB-90和TSB-91。在培养过程中，对其生物学特性进行了细胞和亚细胞水平的探讨，并进行了核型分析。发现2个细胞系核型的演化趋势有明显差异，生物学特性也不尽相同。这可能与膀胱癌组织中细胞的遗传异质性和分化程度有关。对其机制和细节有待进一步深入研究。     

抗体阴性重症肌无力发病与凝集素之间关系研究

借助研究抗体阴性重症肌无力（ＭＧ）发病与凝集素之间的关系，以阐明其发病过程是否与凝集素有关。方法观察伴刀豆球蛋白Ａ（ＣｏｎＡ）和麦胚凝集素（Ｔｒｉｔｉｃｕｍ）及其凝集素－糖复合物对ＴＥ６７１细胞表达的乙酰胆碱受体（ＡＣｈＲ）功能的作用，以及对α－ＢｕＴｘ结合试验的影响。结果有两种凝集素对ＡＣｈＲ功能均有抑制作用，抑制率（％）分别为５４±１４（ｎ＝１１）和４７±１６（ｎ＝１０），此作用可被３种糖抑制，抑制率（％）分别为：９５±５（ｎ＝５）和８４±８（ｎ＝５）；６９±６（ｎ＝４）和６５±５（ｎ＝４）；３９±４（ｎ＝５）和５７±６（ｎ＝５）；ＣｏｎＡ抑制α－ＢｕＴｘ结合试验，而Ｔｒｉｔｉｃｕｍ则不能。结论Ｔｒｉｔｉｃｕｍ和抗体阴性ＭＧ患者非ＩｇＧ部分对ＡＣｈＲ功能和α－ＢｕＴｘ结合试验的作用类同或一致，表明抗体阴性ＭＧ患者非ＩｇＧ部分中的内源性Ｔｒｉｔｉｃｕｍ样糖蛋白在其发病过程中起重要作用。     

Botulinum versus tetanus neurotoxins: Why is botulinum neurotoxin but not tetanus neurotoxin a food poison?

Botulinum and tetanus neurotoxins, produced by Clostridium botulinum and Clostridium tetani, respectively, are the most poisonous poisons known to mankind. Although botulinum and tetanus neurotoxins share several characteristics, such as similar mol. wts, similar macrostructure, virtually identical mode of action, and a strong amino acid sequence homology, the two neurotoxins differ in one very significant way; only botulinum neurotoxin is a food poison. Factors responsible for the food poisoning potential of botulinum neurotoxins seem to be a group of complexing proteins that are also produced by C. botulinum, and are known to associate with the neurotoxin. Translation products of nucleotide sequences upstream to the neurotoxin genes of serotypes A, B, C, D, E and F botulinum neurotoxin reveal the location of genes for one of the complexing proteins that could be transcribed as polycistronic mRNA to include neurotoxin sequences. No such protein seems to be present in C. tetani, suggesting that the lack of complexing proteins might be responsible for tetanus not being a food poison.     

三硝基甲苯急性中毒对小鼠睾丸超微结构的影响

三硝基甲苯急性中毒后,小鼠睾丸的各级生精细胞,支持细胞及睾丸间质细胞的超微结构均有不同程度的改变,精子细胞的损伤较重,精原细胞的损伤较轻.生精细胞的损伤较支持细胞及睾丸间质细胞为重.     

应用低严格度—单引物聚合酶链反应对问号钩体中国参考株的…

Ｇ１、Ｇ２引物是对问号钩体具有特异性引物。分别用Ｇ１或Ｇ２单引物对问号钩体中国参考株进行前４个低严格度循环的ＰＣＲ扩增，扩增带谱显示赖型、犬型、致热型、秋季型、澳洲型、临海型、乌尔夫型、溶血型为一类，而爪哇型、拜伦型、波摩那型、七日热型、巴叶赞型塔拉索夫型、曼耗Ⅱ型是不与以上赖型等血清型本为一类，双曲钩体ａｔｏｃ型及伊利尼细丝体伊利尼型的扩增带谱与问号钩体截然不同。应用苯酚法提取的高纯度钩体ＤＮＡ     

Administration of balanced or BCAA-enriched amino acid solution in septic rats. Effects on protein synthesis in the liver.

Total hepatic protein synthesis was measured in vivo with a flooding-dose technique, and the production of total secreted proteins, albumin, complement component C3, and seromucoid fraction was measured in perfused livers of septic rats that received one of three different solutions infused intravenously; Group 1 received 16.4% dextrose; Group 2 received Aminosyn (25% BCAA) in 10.6% dextrose, and Group 3 received Freamine HBC (45% BCAA) in 10.6% dextrose. All solutions were isocaloric, and the amino acid solutions were isonitrogenous. The solutions were administered for 18 or 48 hours after the induction of sepsis. There were no significant differences in mortality rates in the three treatment groups. The negative nitrogen balance seen in the dextrose-infused animals was reversed to the same degree by the two different amino acid solutions. There were no significant differences in hepatic protein synthesis rates in vivo between the three groups of rats. Synthesis rates of secreted proteins in perfused liver were similar in the different treatment groups in the 18-hour experiments, whereas in the 48-hour experiments, synthesis rates of total secreted proteins, C3, and the serumucoid fraction were higher in Group 1 than in Groups 2 and 3. The results suggest that administration of an amino acid solution improves nitrogen balance in sepsis, but that this effect is not caused by stimulated hepatic protein synthesis. The nitrogen-sparing effect during sepsis of a branched chain amino acid (BCAA)-enriched solution does not seem to be superior to that of a balanced amino acid solution.     

Selection of Streptococcus pneumoniae Mutants Having Reduced Susceptibility to Moxifloxacin and Levofloxacin

With Streptococcus pneumoniae, moxifloxacin was 4- and 10-fold more effective than levofloxacin at restricting selection of resistant mutants and at killing resistant mutants, respectively. The selection frequency for first-step topoisomerase mutants was 1,000 times lower for moxifloxacin than for levofloxacin; this difference was lost when second-step mutants were selected.